 study was by Park et al,201 who had randomized patients with C2 and C3 disease to either endovenous laser ablation of the IPVs in the thigh, followed by
ablation of the GSV below the IPV (n ¼ 34), or ablation
of the GSV starting just proximal to the thigh perforator
without ablation of the perforator vein (n ¼ 35). Technical
success was signiﬁcantly